Medtronic Infuse Bone Graft Failure Allegation Lawsuits Information Bank for Consumers Now Available through Resource4thePeople
Consumers are also offered free legal consultations through Resource4thePeople attorneys over allegations of serious side effects and marketing procedures involving Medtronic Infuse Bone Grafts that were criticized by U.S. Senate investigators.
San Diego, CA (PRWEB) May 15, 2013
Resource4thePeople announced today that it is providing consumers an information bank stocked with important data in connection with the legal proceedings now underway involving allegations that the Medtronic Infuse Bone Grafts may have caused serious, life-threatening health problems.
“This action comes in response to the increasing numbers of consumer inquiries we have been receiving about lawsuits involving allegations that the Medtronic Infuse Bone Grafts were used improperly in medical operations and caused serious side effects to patients,” said Resource4thePeople.
“At the same time, our national network of attorneys is continuing to offer free consultations to consumers who are alleging that they were harmed in operations in which they had Medtronic Infuse Bone Graft systems implanted in their bodies.”
Resource4thePeople attorneys are accepting inquiries from consumers about their legal rights to seek compensation in connection with alleged serious health side effects such as severe back and leg pain, infections, bone deterioration, sterility and cancer.
The information being provided consumers at the Resource4thePeople web site includes some of the latest information about Medtronic Infuse Bone Graft lawsuits that have been filed, court rulings, affected products and model numbers and signs and symptoms of possible side effects.
“Also being provided is some of the information from the Food and Drug Administration´s Feb. 16, 2011 Class 1 Recall* of Medtronic Infuse Bone Graft pumps and refill kits which, the FDA said, ℠may result in patient harm, serious injury, and/or death due to drug overdose or underdose,´” said Resource4thePeople.
Class I recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death.
Resource4thePeople also notes that a federal lawsuit** was filed in March in the Southern District of Ohio against Medtronic Inc. and an Ohio surgeon who, according to complaint, was a paid Medtronic consultant in addition to his professional duties.
The lawsuit includes allegations that 88 patients are claiming that underwent spine surgeries involving bone protein that they did not consent to and have suffered detrimental side effects for which they are seeking compensation.
The lawsuit claims that “medically unnecessary, experimental spine surgeries” were performed “using falsely and improperly marketed Medtronic medical devices and drugs,” according to allegations contained in the court file.
Resource4thePeople also said that the allegations filed in the new lawsuit raise more questions about the relationships between physicians and Medtronic over fees paid to the doctors that have come under criticism*** from U.S. Senate Finance Committee investigators.
“The revelations included in the Oct. 25, 2012 report by the Senate Finance Committee involving payments to doctors and the downplaying of dangerous side effects from this medical device have raised serious questions among patients who underwent these surgeries and have contacted us,” said Resource4thePeople spokesman William Howell.
Resource4thePeople said that over the last few months such inquiries have increased as a result of news media reports about the findings of the committee´s investigation into Medtronic´s spending of millions of dollars to doctors and researchers in return for studies favorable to the Infuse device.
The Medtronic Infuse bone graft was approved by the Food and Drug Administration as a sanctioned medical device designed to stimulate spinal bone growth in patients suffering from lower spine degenerative diseases.
“Resource4thePeople is shocked by the findings of the Senate Finance Committee which, in very strongly worded language, said that Medtronic essentially attempted to sway public opinion about the safety of their product by paying millions of dollars to doctors and researchers to write positive reviews,” the organization said in announcing the legal referrals.
“When a bipartisan committee issues such a report it obviously shows the strong feelings that our elected officials have about a medical device company shielding negative facts about the safety of their product from consumers while paying to have positive information circulated in respected medical journals.”
Resource4thePeople also is recommending that any patient who had a Medtronic Infuse bone graft take the time to read the report that was issued jointly by Committee Chairman Max Baucus (D-Mont.) and senior member Chuck Grassley (R-Iowa) after the 16-month investigation into Medtronic revealed questionable ties between the medical technology and medical research findings.
“Medtronic´s actions violate the trust patients have in their medical care. Medical journal articles should convey an accurate picture of the risks and benefits of drugs and medical devices, but patients are at serious risk when companies distort the facts the way Medtronic has,” Senator Baucus said. “Patients everywhere will be better served by a more open, honest system without this kind of collusion.”
“These findings emphasize the value of the Grassley-Kohl Physician Payments Sunshine Act, which will result in public disclosure of industry payments to physicians starting next year. The findings also should prompt medical journals to take a very proactive approach to accounting for the content of the articles along with the authorship of the articles and studies they feature,” Grassley said.
“Resource4thePeople also notes that there have long been concerns about the safety of the cervical spine fusions and that FDA issued a Public Health Notification in 2008 warning about life-threatening complications associated with recombinant human bone morphogenetic protein in cervical spine fusion.****
**Case # 1:13cv0202 U.S. District Court, Southern District of Ohio
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/5/prweb10728984.htm